We are live on ! Find out more
KANG

iKang Healthcare Group, Inc.
KANG

Delisted

KANG was delisted on the 18th of January, 2019.

59 hedge funds and large institutions have $369M invested in iKang Healthcare Group, Inc. in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

133% more funds holding in top 10

Funds holding in top 10: 37 (+4)

23% more capital invested

Capital invested by funds: $299M → $369M (+$70.1M)

13% more funds holding

Funds holding: 5259 (+7)

5% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 19

98% less call options, than puts

Call options by funds: $501K | Put options by funds: $22M

Holders
59
Holders Change
+7
Holders Change %
+13.46%
% of All Funds
1.34%
Holding in Top 10
7
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+133.33%
% of All Funds
0.16%
New
10
Increased
18
Reduced
19
Closed
3
Calls
$501K
Puts
$22M
Net Calls
-$21.5M
Net Calls Change
-$3.14M
Name Holding Trade Value Shares
Change
Change in
Stake
FI
1
Fosun International
China
$72.8M +$15M +1,039,296 +29%
Goldman Sachs
2
Goldman Sachs
New York
$69.2M -$218K -15,120 -0.3%
GP
3
GLG Partners
United Kingdom
$29.8M +$899K +62,233 +3%
MCP
4
Maso Capital Partners
Hong Kong
$23.8M
HIM
5
Hillhouse Investment Management
Cayman Islands
$19.9M
QF
6
QVT Financial
New York
$15M -$7.94M -549,402 -37%
Fidelity International
7
Fidelity International
Bermuda
$14.7M -$4.53M -313,848 -25%
BlackRock
8
BlackRock
New York
$12.7M +$635K +43,981 +6%
Wellington Management Group
9
Wellington Management Group
Massachusetts
$10.2M +$8.99M +622,140 +2,722%
First Manhattan
10
First Manhattan
New York
$7.63M -$6.44M -445,700 -48%
Group One Trading
11
Group One Trading
Illinois
$7.6M -$3.56M -246,389 -34%
AC
12
Athos Capital
Hong Kong
$7.6M -$2.82M -195,097 -29%
Hudson Bay Capital Management
13
Hudson Bay Capital Management
Connecticut
$6.15M
OAM
14
Oxford Asset Management
United Kingdom
$5.77M -$2.16M -149,349 -29%
CS
15
Credit Suisse
Switzerland
$5.75M +$104K +7,181 +2%
SAM
16
Silphium Asset Management
United Kingdom
$5.74M +$5.24M +363,017 New
KCMH
17
Kontiki Capital Management (HK)
Hong Kong
$5.28M +$4.82M +333,913 New
Vanguard Group
18
Vanguard Group
Pennsylvania
$4.9M +$3.59M +248,455 +403%
CI
19
Conning Inc
Connecticut
$4.74M
Millennium Management
20
Millennium Management
New York
$4.14M
Norges Bank
21
Norges Bank
Norway
$3.26M +$2.98M +206,234 New
CL
22
CSS LLC
Illinois
$3.02M
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$2.81M +$412K +28,488 +19%
SVI
24
Strategic Vision Investment
Hong Kong
$2.47M +$2.26M +156,459 New
State Street
25
State Street
Massachusetts
$2.45M +$229K +15,844 +11%

KANG Hedge Fund Activity: Q4 2017 in Review

59 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q4 2017, worth a combined $369M — up 23% from $299M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new KANG positions and 3 closed out — a net gain of 7 holders — while 18 added to existing stakes and 19 trimmed.

The largest buyer was Fosun International, adding an estimated $15M. The largest seller was QVT Financial, cutting an estimated $7.94M.

  • 59 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q4 2017, up from 52 in Q3 2017.
  • Funds reported $369M of iKang Healthcare Group, Inc. stock for Q4 2017, up 23% quarter-over-quarter.
  • 10 funds opened new iKang Healthcare Group, Inc. positions in Q4 2017 and 3 closed out, a net change of +7 holders.
  • The largest iKang Healthcare Group, Inc. buyer in Q4 2017 was Fosun International, an estimated $15M added.
  • The largest iKang Healthcare Group, Inc. seller in Q4 2017 was QVT Financial, an estimated $7.94M sold.

Based on aggregated 13F filings for Q4 2017.